Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02575885 · ClinicalTrials.gov registry record · NA
Nicotine Delivery From Novel Non-Tobacco Electronic System in Smokers
A NA study, sponsored by Roswell Park Cancer Institute.
- Completed
- Registry status
- NA
- Development phase
- 36
- Enrollment target
NCT02575885 is a NA study that has completed, run by Roswell Park Cancer Institute. The registered enrollment target is 36 participants.
The verdict
NCT02575885, a NA study, has completed, sponsored by Roswell Park Cancer Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 36 participants
- Enrollment target
Study Summary
This randomized pilot clinical trial studies nicotine delivery from novel non-tobacco electronic system (ENDS) in smokers. Studying the levels of nicotine delivered by various types and brands of ENDS to the bloodstream, and comparing this to the levels delivered from conventional cigarettes (the participant's own brand) may help provide information about the use of nicotine-containing products that may help inform/reform current tobacco policy, practice, and harm reduction approaches.
Interventions
- OTHER Laboratory Biomarker Analysis
- OTHER Questionnaire Administration
- OTHER Pharmacological Study
- OTHER Electronic Cigarette
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2016-03-16 |
| Est. Completion | 2018-06-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02575885
The ClinicalTrials.gov registry entry for NCT02575885 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Roswell Park Cancer Institute, which has 365 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Laboratory Biomarker Analysis is the first listed.
NCT02575885 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02575885 about?
NCT02575885 is a clinical study titled "Nicotine Delivery From Novel Non-Tobacco Electronic System in Smokers". This randomized pilot clinical trial studies nicotine delivery from novel non-tobacco electronic system (ENDS) in smokers. Studying the levels of nicotine delivered by various types and brands of ENDS to the bloodstream, and comparing this to the levels delivered from conventional cigarettes (the pa...
What is the current status of trial NCT02575885?
This trial is currently completed. It is a NA study. The enrollment target is 36 participants. The study started on 2016-03-16. Estimated completion is 2018-06-06.
What interventions are being tested in trial NCT02575885?
The interventions under investigation include: Laboratory Biomarker Analysis (OTHER), Questionnaire Administration (OTHER), Pharmacological Study (OTHER), Electronic Cigarette (OTHER).
Who is sponsoring clinical trial NCT02575885?
This trial is sponsored by Roswell Park Cancer Institute, which has 365 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.